Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.
about
The role of Transient Receptor Potential Vanilloid 1 (TRPV1) channels in pancreatitisRoad map for pain management in pancreatic cancer: A reviewCurrent understanding of the neuropathophysiology of pain in chronic pancreatitisSynthetic and Biological Studies of Sesquiterpene Polygodial: Activity of 9-Epipolygodial against Drug-Resistant Cancer CellsPolymorphisms in gene encoding TRPV1-receptor involved in pain perception are unrelated to chronic pancreatitis.Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain.Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells.Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic adenocarcinoma.Involvement of Transient Receptor Potential Melastatin 7 Channels in Sophorae Radix-induced Apoptosis in Cancer Cells: Sophorae Radix and TRPM7.hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α proteinVanilloids induce oral cancer apoptosis independent of TRPV1.Responses of human adipose-derived mesenchymal stem cells to chemical microenvironment of the intervertebral disc.Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary aminesInvolvement of the phosphoinositide 3-kinase/Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1Vanilloid-induced conduction analgesia: selective, dose-dependent, long-lasting, with a low level of potential neurotoxicity.Involvement of endoplasmic reticulum stress in capsaicin-induced apoptosis of human pancreatic cancer cellsPain management in pancreatic cancer.Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis.Animal models of cancer pain.Submembraneous microtubule cytoskeleton: biochemical and functional interplay of TRP channels with the cytoskeleton.Perineural invasion and associated pain in pancreatic cancer.Unraveling the mystery of pain in chronic pancreatitis.Pain and chronic pancreatitis: a complex interplay of multiple mechanisms.Pain in Patients with Pancreatic Cancer: Prevalence, Mechanisms, Management and Future Developments.Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain PathwaysInsulin-secreting INS-1E cells express functional TRPV1 channels.Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling.Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients.Haemorrhoids and transient receptor potential vanilloid 1.Calcium channel expression and applicability as targeted therapies in melanoma.Anti-cancer Activity of Natural and Synthetic Capsaicin Analogs.Acidosis and Formaldehyde Secretion as a Possible Pathway of Cancer Pain and Options for Improved Cancer Pain Control.5-Fluorouracil-induced mitochondrial oxidative cytotoxicity and apoptosis are increased in MCF-7 human breast cancer cells by TRPV1 channel activation but not Hypericum perforatum treatment.Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain.
P2860
Q24679996-F96F7C33-CC78-4BEE-B0F8-4D83D7EC25E5Q26738297-8AD2E818-2C29-49D6-96F5-990ED4BC1DFFQ26776148-BE4F6DA3-EAF3-4329-8211-589419161F72Q28834689-DEC816A2-32E8-4D14-9A63-42EEDE120D0AQ33520752-6DA834A4-A9A0-47DE-A476-DA8557A0B456Q33565555-2CAEF3A3-1338-4D17-A584-11C9B6ACAFEBQ33925357-0CB55D7F-05DF-4CAB-8C36-590E9C526D28Q34106466-8516CE56-02CE-44B9-B367-954666986A7CQ35093525-795D2D4F-588A-4118-A962-F332A2658E46Q35198312-0F7FD8C6-0705-4617-ABCF-0D22C2BD881EQ35376123-4C097B08-DA7E-42BE-A63F-7B8389BBE511Q35565649-75ABAC89-D3C7-4CB3-A0C8-7429CE02F148Q35916880-5A6FC89A-DAD9-4A35-85F7-36B198DEF5AAQ36198988-205CCF3B-0B81-4C99-96C5-4F9137E753BCQ36475743-9D1E07A0-83E4-40DB-A071-312C1AE0B548Q36813584-F54A0FC8-433B-4ADE-AC3F-5D6910C312A2Q36921824-030D0ED1-92F0-450D-A9B5-3BD1A961A330Q37129741-91223D88-F26E-467C-88EB-99C3CE6F6D5AQ37158913-96F396A2-B1E6-460C-8A76-AB762ED0ACABQ37203216-BFEAF580-F50E-4ECC-BE62-E29D08E4305AQ37255247-0DDC86AF-8562-42AD-AFB1-A3FC221ACDD6Q37937421-09C98646-6867-4AA8-A5C0-868B8B2A51A6Q37978115-004404D0-8F97-4D6A-AFD2-C78ACFB3EA63Q38164701-127F76B2-F527-4227-8677-E166B89D5795Q38754349-5FC1EB00-8CC5-48A8-A83F-13459403D115Q38828988-14FCF4BA-294D-43EF-AAD4-A34B356848E4Q39406909-3FD41CCF-19FE-4D42-857A-8477B67867E9Q39612036-61825872-9687-46F3-8749-36A8D5D4B916Q41812457-4B3B0FDB-1AC0-4949-B639-F34C275B6CD1Q42836001-B995E951-83D2-4E91-B278-302C95AE20C1Q43150732-EF1ECDCC-682A-492F-8D8C-BEFA46760C45Q47778782-7D03755C-32CD-4220-9DB1-55B7050C3321Q47965820-31C58647-4371-4BDA-8151-D5E4BB445DF1Q48262534-18E5CC53-AAC1-4EBD-823B-7FB7D285A975Q54273275-5F12B0EE-40F8-4C02-9A35-0C8DFED1A275
P2860
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.
@ast
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.
@en
type
label
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.
@ast
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.
@en
prefLabel
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.
@ast
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.
@en
P2093
P2860
P356
P1433
P1476
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management
@en
P2093
F Selvaggi
G Mascetta
M W Büchler
P2860
P304
P356
10.1136/GUT.2005.073205
P407
P577
2005-09-20T00:00:00Z